Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
European Journal of Pediatrics|January 20, 2022
Body mass index in type 2 spinal muscular atrophy: a longitudinal studyGloria Ferrantini, Giorgia Coratti, Roberta Onesimo, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 22, 2023
Early treatment of type II SMA slows rate of progression of scoliosisGiorgia Coratti, Jacopo Lenkowicz, Maria Carmela Pera, et al.Annals of Clinical and Translational Neurology|February 15, 2022
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophyMarika Pane, Giorgia Coratti, Maria Carmela Pera, et al.Eclinicalmedicine|May 17, 2023
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapiesMarika Pane, Beatrice Berti, Anna Capasso, et al.Neuropathology and Applied Neurobiology|July 29, 2022
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatmentChiara Fiorillo, Giovanna Capodivento, Alessandro Geroldi, et al.European Journal of Pediatrics|June 9, 2025
Italian validation of the SMA independence scale-upper limb moduleChiara Bravetti, Giorgia Coratti, Maria Carmela Pera, et al.Neuromuscular Disorders : NMD|June 27, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMAGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.European Journal of Neurology|March 7, 2023
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar functionMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.Neuromuscular Disorders : NMD|September 19, 2024
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb ModuleGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.Pageof 4